Effect of catumaxomab on EpCAM+ tumor cells in vitro in the presence of immune effector cells from ovarian cancer patients treated with chemotherapy.
K. Pietzner
No relevant relationships to disclose
J. Sehouli
No relevant relationships to disclose
J. Atz
Employment or Leadership Position - Fresenius Biotech
Stock Ownership - Fresenius Biotech
K. Dettmar
Employment or Leadership Position - Fresenius Biotech
Stock Ownership - Fresenius Biotech
H. Martinius
Employment or Leadership Position - Fresenius Biotech
Stock Ownership - Fresenius Biotech
R. Spannagl
Employment or Leadership Position - Fresenius Biotech
Stock Ownership - Fresenius Biotech
D. Seimetz
Employment or Leadership Position - Fresenius Biotech
Stock Ownership - Fresenius Biotech
P. Schroeder
Employment or Leadership Position - EUFETS GmbH
Other Remuneration - Fresenius Biotech
H. Lindhofer
Employment or Leadership Position - TRION Pharma
Stock Ownership - TRION Pharma
G. Oskay-Ă–zcelik
No relevant relationships to disclose
R. Chekerov
No relevant relationships to disclose
E. I. Braicu
No relevant relationships to disclose